Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) EBT (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of EBT data on record, last reported at $3.3 million in Q3 2025.

  • For Q3 2025, EBT fell 20.82% year-over-year to $3.3 million; the TTM value through Sep 2025 reached $15.2 million, up 115.81%, while the annual FY2024 figure was $16.8 million, 16.36% down from the prior year.
  • EBT reached $3.3 million in Q3 2025 per UTMD's latest filing, down from $3.8 million in the prior quarter.
  • Across five years, EBT topped out at $16.8 million in Q4 2024 and bottomed at -$6.9 million in Q4 2022.
  • Average EBT over 5 years is $4.1 million, with a median of $4.8 million recorded in 2023.
  • Peak YoY movement for EBT: crashed 232.87% in 2022, then skyrocketed 373.07% in 2024.
  • A 5-year view of EBT shows it stood at $5.2 million in 2021, then plummeted by 232.87% to -$6.9 million in 2022, then increased by 10.62% to -$6.2 million in 2023, then surged by 373.07% to $16.8 million in 2024, then tumbled by 80.31% to $3.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $3.3 million in Q3 2025, $3.8 million in Q2 2025, and $3.9 million in Q1 2025.